Feature | June 20, 2012

Role of Echocardiography in TAVR to be Demonstrated Live at ASE 2012

An angiographic image showing a transesophogeal Echo (TEE) probe in use during deployment of a transcatheter Sapien aortic valve.

June 20, 2012 — Echocardiography is playing a key role in both the assessment and guidance of transcatheter aortic valve replacement (TAVR). Attendees at the American Society of Echocardiography’s 23rd Annual Scientific Sessions will have the opportunity to see this in action during a live TAVR procedure transmitted from Washington Hospital Center's hybrid cath lab.

The value of TAVR depends on careful selection of patients who, while not surgical candidates, do not have such extreme comorbidities that overwhelm the benefits of TAVR and render the intervention futile. In selection of these patients, Doppler echocardiography has now replaced cardiac catheterization as the gold standard diagnostic technique for quantifying aortic stenosis (AS), the most common valvular heart condition in the elderly. A transthoracic echocardiogram (TTE), in which an external probe is placed on the patient’s chest, can determine whether the AS is severe enough for TAVR. Transesophageal echocardiography (TEE), in which an ultrasound probe is passed into the patient’s esophagus, supplements the information from TTE, providing precise measurements of the ring surrounding the aortic valve, critical for selecting the proper size of the implanted valve.  And, the role for echocardiography doesn’t stop with diagnosis and decisions on treatment, as TEE is widely used to guide device placement during the TAVR procedure.

Steven Goldstein, M.D.,  a cardiologist at MedStar Heart Institute, will lead a team of interventional experts during the surgery at the center. Due to the design of the hybrid cath lab at Washington Medical Center, the audience will be able to see information from various monitors, including echo images, fluoroscopic images and pressure tracings. 

For more information: www.asecho.org

 

Related Content

Sci-image, Scimage, CVIS, CIIMS, Cpacs c-pacs, cardiovascular information system

Today's cardiovascular information systems need to incorporate all facets of the cardiology department, including subspecialties, to allow a complete picture of a patient's record. These data also need to be able to be shared with enterprise data systems, such as the electronic medical record (EMR). This image is from ScImage, illustrating the various aspects that integrate to make up a complete CVIS. 

 

Feature | September 29, 2016 | Val Kapitula, RT(R), PMP, CIIP
Cardiovascular Information and Imaging Systems (CVIS) have existed for many years in the dedicated sub-specialty area
Keystone Heart, TriGuard Embolic Protection Device, real-world results, PCR London Valves Conference 2016
News | Embolic Protection Devices| September 29, 2016
Keystone Heart Ltd. recently announced the safety and efficacy of the TriGuard Cerebral Embolic Protection device...
TCT 2016, TCT.16, main arena, late breaking trials
Feature | Cath Lab| September 28, 2016
September 28, 2016 — The Cardiovascular Research Foundation (CRF) has announced the 11 late-breaking trials and 16 fi
4Tech, TriCinch TTVR, transcather tricuspid valve repair device, first implant
News | Heart Valve Technology| September 22, 2016
4Tech Inc. announced that its TriCinch device has been used in the world’s first-ever successful transcatheter...
GE Healthcare, Vivid iq portable cardiovascular ultrasound, RSNA 2016, launch
Technology | Cardiovascular Ultrasound| September 22, 2016
September 22, 2016 — GE Healthcare announced the global commercial launch of its new generation of high-end portable
Transesophageal Echo, TEE. Interventional echocardiography, interventional echo, Philips, CX50

Transesophageal echo (TEE) has become an essential part of the new transcatheter structrual heart therapies, giving rise to a new sub-speciality of interventional echocardiography.  

Feature | Cath Lab Navigation Aids| September 21, 2016 | Dave Fornell
The rapid growth of transcatheter structural heart procedures and the need for increased use of echocardiography as a
Claret Medical, Sentinal CPS, cerebral protection system, FDA marketing application, TAVR, embolic protection
News | Embolic Protection Devices| September 20, 2016
Claret Medical announced its filing of a marketing application with the U.S. Food and Drug Administration (FDA) for...
Edwards sapien, intermediate risk patients, CE mark
News | Heart Valve Technology| September 20, 2016
September 19, 2016 — Edwards Lifesciences received European CE mark to expand use of the Edwards Sapien 3 transcathet
Valtech Cardio, Cardioband Tricuspid, Cardioband Mitral, PCR London Valves 2016, study data
News | Heart Valve Technology| September 19, 2016
Valtech Cardio Ltd. announced that it will present the first-in-man data for its Cardioband Tricuspid (TR) system at...
Lotus Edge Valve, CE mark, boston scientific, TAVR, TAVI

The Lotus Edge system in its deployed position. The Lotus valve expands outward as it is compressed and buckled in the deployment position. It also has a skirt to help eliminate paravalvular leaks.

News | Heart Valve Technology| September 19, 2016
September 19, 2016 — Boston Scientific received European CE mark approval for its Lotus Edge Valve System, the compan
Overlay Init